148 related articles for article (PubMed ID: 23095143)
21. Invasive bladder cancer following 125iodine implants.
Winters JC; Fuselier HA
J Urol; 1992 Dec; 148(6):1898-900. PubMed ID: 1433634
[TBL] [Abstract][Full Text] [Related]
22. Cardiac sarcoma 14 years after treatment for pleural mesothelioma.
Neragi-Miandoab S; Gangadharan SP; Sugarbaker DJ
N Engl J Med; 2005 May; 352(18):1929-30. PubMed ID: 15872213
[No Abstract] [Full Text] [Related]
23. Post-irradiation sarcoma after external beam radiation therapy for localized adenocarcinoma of the prostate.
Prevost JB; Bossi A; Sciot R; Debiec-Rychter M
Tumori; 2004; 90(6):618-21. PubMed ID: 15762367
[TBL] [Abstract][Full Text] [Related]
24. Subacute penile numbness after brachytherapy for prostate cancer.
Sharp HJ; Swanson DA; Patel H; Gorbatiy V; Frenzel JC; Frank SJ
Brachytherapy; 2011; 10(1):64-7. PubMed ID: 20685173
[TBL] [Abstract][Full Text] [Related]
25. Incidence and clinical course of hemorrhagic radiation proctitis after iodine-125 prostate brachytherapy.
Mishra MV; Shirazi R; Barrett WL
Clin Genitourin Cancer; 2007 Sep; 5(6):397-400. PubMed ID: 17956713
[TBL] [Abstract][Full Text] [Related]
26. Early quality of life outcomes in patients with prostate cancer managed by high-dose-rate brachytherapy as monotherapy.
Komiya A; Fujiuchi Y; Ito T; Morii A; Yasuda K; Watanabe A; Nozaki T; Iida H; Nomura K; Fuse H
Int J Urol; 2013 Feb; 20(2):185-92. PubMed ID: 22905941
[TBL] [Abstract][Full Text] [Related]
27. High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: a Phase II trial.
Barkati M; Williams SG; Foroudi F; Tai KH; Chander S; van Dyk S; See A; Duchesne GM
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1889-96. PubMed ID: 21550182
[TBL] [Abstract][Full Text] [Related]
28. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
29. Radiation-associated sarcoma after recurrent colorectal primary tumor: A complex surgical case.
Stephen AH; Fallon EA; Kalife E; Wanebo H
J Surg Oncol; 2015 Nov; 112(6):658-61. PubMed ID: 26430853
[TBL] [Abstract][Full Text] [Related]
30. Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy.
Abdel-Wahab M; Reis IM; Hamilton K
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):58-68. PubMed ID: 18374503
[TBL] [Abstract][Full Text] [Related]
31. Rectal adenocarcinoma with rectoprostatic fistula following prostate brachytherapy.
Moss BF; Peracha AM
BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30936326
[TBL] [Abstract][Full Text] [Related]
32. Brachytherapy for clinically localized prostate cancer: optimal patient selection.
Kollmeier MA; Zelefsky MJ
Arch Esp Urol; 2011 Oct; 64(8):847-57. PubMed ID: 22052766
[TBL] [Abstract][Full Text] [Related]
33. Prostate cancer: 7. Radiation therapy for localized disease.
Warde P; Catton C; Gospodarowicz MK
CMAJ; 1998 Dec; 159(11):1381-8. PubMed ID: 9861209
[No Abstract] [Full Text] [Related]
34. Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate.
Lawton CA; Yan Y; Lee WR; Gillin M; Firat S; Baikadi M; Crook J; Kuettel M; Morton G; Sandler H
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e795-801. PubMed ID: 22330999
[TBL] [Abstract][Full Text] [Related]
35. When prostate brachytherapy fails: a case report and discussion.
Kadoch C; D'Amico AV; Matthews RH
Oncologist; 2005; 10(10):799-805. PubMed ID: 16314290
[TBL] [Abstract][Full Text] [Related]
36. Rectourethral fistula after combination radiotherapy for prostate cancer.
Marguet C; Raj GV; Brashears JH; Anscher MS; Ludwig K; Mouraviev V; Robertson CN; Polascik TJ
Urology; 2007 May; 69(5):898-901. PubMed ID: 17482930
[TBL] [Abstract][Full Text] [Related]
37. Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP Publication 98.
International Commission on Radiological Protection
Ann ICRP; 2005; 35(3):iii-vi, 3-50. PubMed ID: 16330284
[TBL] [Abstract][Full Text] [Related]
38. [Surveillance after prostate cancer radiotherapy].
Supiot S; Rio E; Clément-Colmou K; Bouchot O; Rigaud J
Cancer Radiother; 2011 Oct; 15(6-7):540-5. PubMed ID: 21795093
[TBL] [Abstract][Full Text] [Related]
39. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy.
Mabjeesh NJ; Chen J; Stenger A; Matzkin H
Urology; 2007 Sep; 70(3):548-53. PubMed ID: 17905113
[TBL] [Abstract][Full Text] [Related]
40. Prostate brachytherapy--the community hospital experience.
Percarpio B; Sanchez P; Kraus P; Corujo M; D'Addario P; Wolk J
Conn Med; 2000 Sep; 64(9):523-6. PubMed ID: 11055085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
